More specifically in gliomas, CD109 has been proposed as a marker of perivascular GSCs (20), and very recent reports indicate a clear association between CD109 and GSC stemness maintenance and disease recurrence (21, 22). The gene discussed is CD109; the disease is central nervous system cancer.